Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of pravastatin therapy on serum lipids and coronary reactivity are not associated with SREBP cleavage-activating protein polymorphism in healthy young men.

Clinical genetics - 1 Oct 2001

Fan Y M, Laaksonen R, Janatuinen T, Vesalainen R, Nuutila P, Knuuti J, Lehtimäki T

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analysis of Variance
Share to Blood Flow Velocity
Share to Coronary Artery Disease
Share to Coronary Circulation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Electrocardiography

Share to Lipids

Share to Pravastatin

Source

Identifiers

PMID: 11683781
DOI: 10.1034/j.1399-0004.2001.600413.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of pravastatin therapy on serum lipids and coronary reactivity are not associated with SREBP cleavage-activating protein polymorphism in healthy young men.PMID 11683781Read ↗

Impact of atorvastatin treatment in first-degree relatives of patients with premature coronary artery disease with endothelial dysfunction: a double-blind, randomized, placebo-controlled crossover trial.Semantic proximity Read ↗

Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events.Semantic proximity Read ↗

In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study.Semantic proximity Read ↗

Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin.Semantic proximity Read ↗

A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study.Semantic proximity Read ↗

Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS).Semantic proximity Read ↗

Effect of intensive atorvastatin therapy on coronary atherosclerosis progression, composition, arterial remodeling, and microvascular function.Semantic proximity Read ↗

Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy.Semantic proximity Read ↗

Atorvastatin and hormone therapy effects on APOE mRNA expression in hypercholesterolemic postmenopausal women.Semantic proximity Read ↗

Time course differences for statin-induced pleiotropic effects in hypercholesterolemic patients.Semantic proximity Read ↗

Evidence for Statin Pleiotropy in HumansSemantic proximity Read ↗

Short-term treatment with low-dose pravastatin attenuates oxidative susceptibility of low-density lipoprotein in hypercholesterolemic patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.